Gregory S. Day, MD
Neurologist, dementia specialist, clinical researcher
Chair, Geriatric Neurology Quality Measures Work Group, American Academy of Neurology, 2021-present.
Co-principal investigator, The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis, National Institute of Neurological Disorders and Stroke, 2021-present.
Director, Division of Behavioral Neurology, Department of Neurology, Mayo Clinic, 2021-present.
Vice chair of research, Department of Neurology, Mayo Clinic, 2021-present.
Award on the Aging Nervous System; Robert and Arlene Kogod Center on Aging, Department of Neuroscience and Department of Neurology; Mayo Clinic; 2024.
Profile for Gregory S. Day (opens in a new tab) Email Gregory S. Day